Cargando…

Multi-Level Analysis and Identification of Tumor Mutational Burden Genes across Cancer Types

Tumor mutational burden (TMB) is considered a potential biomarker for predicting the response and effect of immune checkpoint inhibitors (ICIs). However, there are still inconsistent standards of gene panels using next-generation sequencing and poor correlation between the TMB genes, immune cell inf...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuangkuai, Tong, Yuantao, Zong, Hui, Xu, Xuewen, Crabbe, M. James C., Wang, Ying, Zhang, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8872466/ https://www.ncbi.nlm.nih.gov/pubmed/35205408 http://dx.doi.org/10.3390/genes13020365

Ejemplares similares

Large-Scale Biomedical Relation Extraction Across Diverse Relation Types: Model Development and Usability Study on COVID-19
por: Zhang, Zeyu, et al.
Publicado: (2023)

GIDB: a knowledge database for the automated curation and multidimensional analysis of molecular signatures in gastrointestinal cancer
por: Wang, Ying, et al.
Publicado: (2019)

ViMRT: a text-mining tool and search engine for automated virus mutation recognition
por: Tong, Yuantao, et al.
Publicado: (2022)

Canine tumor mutational burden is correlated with TP53 mutation across tumor types and breeds
por: Alsaihati, Burair A., et al.
Publicado: (2021)

Multiomics analysis of tumor mutational burden across cancer types
por: Li, Lin, et al.
Publicado: (2021)

Identification of tumor mutation burden-associated molecular and clinical features in cancer by analyzing multi-omics data
por: Li, Mengyuan, et al.
Publicado: (2023)

Identification of Three Core Secretome Genes Associated with Immune Infiltration in High Tumor Mutation Burden Across 14 Major Solid Tumors
por: Wu, Huan, et al.
Publicado: (2021)

ViMIC: a database of human disease-related virus mutations, integration sites and cis-effects
por: Wang, Ying, et al.
Publicado: (2021)

Identification of Tumor Mutation Burden and Immune Infiltrates in Hepatocellular Carcinoma Based on Multi-Omics Analysis
por: Yin, Lu, et al.
Publicado: (2021)

TMBcat: A multi-endpoint p-value criterion on different discrepancy metrics for superiorly inferring tumor mutation burden thresholds
por: Wang, Yixuan, et al.
Publicado: (2022)

Estimating tumor mutational burden across multiple cancer types using whole-exome sequencing
por: Zhou, Chuang, et al.
Publicado: (2021)

Immune Determinants of the Association between Tumor Mutational Burden and Immunotherapy Response across Cancer Types
por: Sinha, Neelam, et al.
Publicado: (2022)

Beyond Tumor Mutation Burden: Tumor Neoantigen Burden as a Biomarker for Immunotherapy and Other Types of Therapy
por: Wang, Peipei, et al.
Publicado: (2021)

Identification of tumor mutation burden-related hub genes and the underlying mechanism in melanoma
por: Zhang, Chuan, et al.
Publicado: (2021)

The predictive efficacy of tumor mutation burden in immunotherapy across multiple cancer types: A meta-analysis and bioinformatics analysis
por: Cao, Jinlong, et al.
Publicado: (2022)

Association of Tumor Mutational Burden and Immune Gene Expression with Response to PD-1 Blockade by Sasanlimab Across Tumor Types and Routes of Administration
por: Hu-Lieskovan, Siwen, et al.
Publicado: (2021)

Comprehensive identification of mutational cancer driver genes across 12 tumor types
por: Tamborero, David, et al.
Publicado: (2013)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma
por: Peng, Ying-Peng, et al.
Publicado: (2021)

A Joint Model Considering Measurement Errors for Optimally Identifying Tumor Mutation Burden Threshold
por: Wang, Yixuan, et al.
Publicado: (2022)

Impact of tumor mutational burden on checkpoint inhibitor drug eligibility and outcomes across racial groups
por: Hsiehchen, David, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden
por: Lin, Jiaqiong, et al.
Publicado: (2020)

Exploration of the Tumor Mutational Burden as a Prognostic Biomarker and Related Hub Gene Identification in Prostate Cancer
por: Wang, Licheng, et al.
Publicado: (2021)

Tumor mutational burden is associated with poor outcomes in diffuse glioma
por: Wang, Lihong, et al.
Publicado: (2020)

The frequency and inter-relationship of PD-L1 expression and tumour mutational burden across multiple types of advanced solid tumours in China
por: Chen, Yanhui, et al.
Publicado: (2020)

MicroRNAs Expression Patterns Predict Tumor Mutational Burden in Colorectal Cancer
por: Huang, Jiahao, et al.
Publicado: (2021)

Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors
por: Wang, Zi‐Ming, et al.
Publicado: (2021)

Comprehensive analysis of tumor mutation burden and immune microenvironment in gastric cancer
por: Yu, Jie, et al.
Publicado: (2021)

Racial disparities in patient survival and tumor mutation burden, and the association between tumor mutation burden and cancer incidence rate
por: Zhang, Wensheng, et al.
Publicado: (2017)

Correlate tumor mutation burden with immune signatures in human cancers
por: Wang, Xiaosheng, et al.
Publicado: (2019)

Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2023)

Identification of neutral tumor evolution across cancer types
por: Williams, Marc J, et al.
Publicado: (2016)

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden
por: Ma, Weijun, et al.
Publicado: (2021)

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
por: Li, Wenjie, et al.
Publicado: (2022)

Development of Tumor Mutation Burden-Related Prognostic Model and Novel Biomarker Identification in Stomach Adenocarcinoma
por: Fu, Min, et al.
Publicado: (2022)

Tumor mutation burden: from comprehensive mutational screening to the clinic
por: Galuppini, Francesca, et al.
Publicado: (2019)

Identification of Salt Tolerance-related microRNAs and Their Targets in Maize (Zea mays L.) Using High-throughput Sequencing and Degradome Analysis
por: Fu, Rong, et al.
Publicado: (2017)

FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer
por: Guo, Zixin, et al.
Publicado: (2021)

The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
por: Xie, Lu, et al.
Publicado: (2021)

Analysis of Threshold Change of Tumor Mutation Burden in Gastric Cancer
por: He, Xinwei, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r663m9do0f9s64k9bs1ue9rla7